The Cooper Companies, Inc. Common Stock (COO) Stock Price

COOStock

$73.04+0.77%52W

Market Cap$14.25B

P/E40.09x

PEG Ratio0.72

Div yield0.02%

Beta0.81

COO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-20.36%

Price vs S&P 500 (4W)2.14%

PEG Ratio0.72

VGM Score52.25

P/E Ratio (Annual)40.09x

Indicated Dividend Yield (Annual)0.02%

P/CF (Annual)18.88x

Book Value / Share (Quarterly)$42.27

P/TBV (Annual)2.09x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.35%

Cash Flow / Share (Quarterly)$2.92

Payout Ratio (TTM)1.63%

Price vs S&P 500 (YTD)-19.47%

Gross Margin (TTM)65.55%

Net Profit Margin (TTM)5.57%

EPS (TTM)$1.18

10-Day Avg Trading Volume1.59M

EPS Excl Extra (TTM)$1.18

Revenue Growth (5Y)10.98%

EPS (Annual)$1.87

Dividend / Share (Annual)$0.00

ROI (Annual)3.49%

Gross Margin (Annual)65.54%

Net Profit Margin (5Y Avg)27.97%

Cash / Share (Quarterly)$0.71

P/E Basic Excl Extra (TTM)63.74x

Revenue Growth QoQ (YoY)7.90%

EPS Growth (5Y)9.30%

P/E Normalized (Annual)40.09x

ROA (Last FY)3.02%

Revenue Growth TTM (YoY)6.09%

EBITD / Share (TTM)$3.51

ROE (5Y Avg)12.22%

Operating Margin (TTM)11.77%

Cash Flow / Share (Annual)$2.21

P/B Ratio1.82x

P/B Ratio (Quarterly)1.49x

Net Income / Employee (Annual)$25,000

EV / Revenue (TTM)4.10x

Net Interest Coverage (TTM)6.25x

ROA (TTM)1.90%

EPS Growth QoQ (YoY)28.28%

EV / EBITDA (TTM)25.03x

EPS Incl Extra (Annual)$1.87

Current Ratio (Annual)1.89x

Quick Ratio (Quarterly)0.53x

3-Month Avg Trading Volume2.58M

52-Week Price Return0.77%

EV / Free Cash Flow (Annual)40.01x

P/E Incl Extra (TTM)63.74x

Revenue / Employee (TTM)$282,100

Tangible BV / Share (Quarterly)$34.61

P/S Ratio (Annual)3.67x

Asset Turnover (Annual)0.33x

52-Week High$89.83

Operating Margin (5Y Avg)16.46%

EPS Excl Extra (Annual)$1.87

CapEx CAGR (5Y)3.15%

Tangible BV CAGR (5Y)21.28%

26-Week Price Return-9.11%

Quick Ratio (Annual)0.84x

13-Week Price Return20.60%

Total Debt / Equity (Annual)0.30x

Current Ratio (Quarterly)1.27x

Enterprise Value$17.35B

Revenue / Share Growth (5Y)10.80%

Asset Turnover (TTM)0.34x

Book Value / Share Growth (5Y)53.92%

Revenue / Employee (Annual)$272,800

Inventory Turnover (Annual)1.71x

Pretax Margin (Annual)13.84%

Cash / Share (Annual)$0.56

3-Month Return Std Dev31.21%

Gross Margin (5Y Avg)66.04%

Net Income / Employee (TTM)$15,700

EBITDA CAGR (5Y)14.46%

EBITDA Interim CAGR (5Y)-37.86%

ROE (Last FY)4.55%

Net Interest Coverage (Annual)5.17x

EPS Basic Excl Extra (Annual)$1.87

P/FCF (TTM)26.39x

Receivables Turnover (TTM)5.32x

EV / Free Cash Flow (TTM)30.47x

Total Debt / Equity (Quarterly)0.30x

EPS Incl Extra (TTM)$1.18

Receivables Turnover (Annual)5.29x

ROI (TTM)2.19%

P/S Ratio (TTM)3.55x

Pretax Margin (5Y Avg)14.29%

Revenue / Share (Annual)$20.46

Tangible BV / Share (Annual)$33.96

Forward P/E14.82x

Free OCF CAGR (5Y)19.74%

Price vs S&P 500 (52W)-17.54%

P/E Ratio (TTM)63.74x

EPS Growth TTM (YoY)-42.61%

Year-to-Date Return-7.52%

5-Day Price Return0.05%

EPS Normalized (Annual)$1.87

ROA (5Y Avg)8.55%

Net Profit Margin (Annual)9.16%

Month-to-Date Return4.81%

Cash Flow / Share (TTM)$12.84

EBITD / Share (Annual)$4.41

EPS Growth (3Y)-1.15%

Operating Margin (Annual)16.69%

LT Debt / Equity (Annual)0.30x

P/CF (TTM)15.77x

ROI (5Y Avg)9.79%

P/E Excl Extra (TTM)63.74x

LT Debt / Equity (Quarterly)0.23x

EPS Basic Excl Extra (TTM)$1.18

P/TBV (Quarterly)1.82x

Payout Ratio (Annual)0.78%

P/B Ratio (Annual)1.69x

Dividend / Share (TTM)$0.00

Inventory Turnover (TTM)1.64x

Pretax Margin (TTM)9.75%

Book Value / Share (Annual)$42.06

Price vs S&P 500 (13W)17.81%

Net Margin Growth (5Y)-1.36%

Dividend Yield (TTM)0.00%

Beta0.81x

P/FCF (Annual)34.66x

Revenue / Share (TTM)$21.70

ROE (TTM)2.84%

52-Week Low$58.89

vGradeC

gGradeC

mGradeC

vgmGradeC

COO Earnings Surprise History

Q2 251.10est. 1.07

Q3 251.15est. 1.11

Q4 251.10est. 1.03

Q1 261.21est. 1.09

COO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.76

3.75

3.83

Industry Peers — Ophthalmic Goods(8)

Symbol	Value Score	Growth Score	Momentum Score	Price
COOThe Cooper Companies, Inc. Common Stock	C	C	C	$73.04
ALCAlcon Inc. Ordinary Shares	C	C	C	$73.37
BLCOBausch + Lomb Corporation	B	C	B	$17.25
WRBYWarby Parker Inc.	D	B	B	$26.00
EYENational Vision Holdings, Inc. Common Stock	B	D	C	$18.69
STAAStaar Surgical Co	D	C	D	$23.18
RXSTRxSight, Inc. Common Stock	B	C	D	$6.40
LUCYInnovative Eyewear, Inc. Common Stock	B	A	C	$1.07
LUCYWInnovative Eyewear, Inc. Series A Warrants 8/16/27	—	—	D	$0.04

About The Cooper Companies, Inc. Common Stock

CooperCompanies operates two leading market segments: CooperVision, which controls approximately 25% of the U.S. contact lens market with brands including Proclear and Biofinity, and CooperSurgical, a reproductive healthcare company with 17% market share in U.S. IUDs and comprehensive IVF device coverage. The company benefits from strong positions in both recurring consumer products and specialized medical devices. CooperVision maintains one of the world's most extensive specialty lens portfolios, while CooperSurgical offers integrated fertility solutions across the IVF cycle.